Recipharm and Medspray, a manufacturer of high-tech spray nozzles, have established Resyca BV, a joint venture to develop and exploit the softmist spray nozzle technology for pharmaceutical applications. The goal is to potentially eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses.   Resyca will operate development facilities in Munich, Germany and spray nozzles will be supplied exclusively from Medspray in the Netherlands. Commerci...